Drugs efficacy evaluations
and much more
LUNG DISEASES BIOMARKERS
Biomarkers have the potential to become central to the clinical evaluation and monitoring of patients with lung diseases.
DIAGNOSTIC AND PROGNOSTIC BIOMARKERS
FOR THE EVALUATION OF INTERSTITIAL LUNG DISEASES
FOR THE EVALUATION OF INTERSTITIAL LUNG DISEASES
- Biomarkers
- Analytical Method
- MMP1, MMP7 and other MMPs
- Multiplex
- IGFBP-2
- ELISA
- VEGF
- Multiplex
- Periostin
- ELISA, Multiplex
- PAI-1
- ELISA
- Exosomes: characterization & sequencing
- ELISA
- Biomarkers
- Analytical Method
- KL-6
- Fujirebio Lumipulse
- SP-A, SP-D
- Multiplex
- MMPs
- Multiplex
- TIMP-1
- Siemens Centaur
- Periostin
- ELISA, Multiplex
- IL-4, IL-6, IL-7, IL-8, IL-12,IL-18, sIL-2R
- Multiplex
- CCL18, CCL2, CCL15, CCL18
- ELISA, Multiplex
- YKL-40
- ELISA
- Exosomes: characterization & sequencing
- ELISA